Navigating eCOA Instrument Licensing and Translation for Pharma and Biotech Professionals

This eye-opening webinar will provide valuable insights into navigating the complexities of eCOA instrument licensing and translation. Participants will gain practical strategies and actionable knowledge from experienced presenters, which will help them streamline their eCOA projects and enhance their implementation expertise.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/ecoa-instrument-licensing
Event overview

Are you at a pharmaceutical or biotechnology company that is grappling with the complexities of eCOA? Initiating an eCOA project can be daunting, especially without the backing of larger, specialized teams. One critical area that demands early, meticulous planning is eCOA instrument licensing and translation.

In this educational webinar, you will gain insights into the importance of eCOA instrument licensing and translation, along with best practices for navigating the intricacies involved. The presenters, who have extensive first-hand experience in the field, will share practical strategies and real-world examples to help streamline your eCOA projects.

You will walk away with actionable knowledge and strategies that can be applied directly to your work to keep your projects on track and within budget. Whether you're new to the world of eCOA or looking to refine your existing processes, this eye-opening webinar will provide a comprehensive guide to enhancing your eCOA implementation expertise! Reserve your spot today and take the first step towards mastering eCOA instrument licensing and translation.


Key Learning Objectives

• Build a strong foundation: Gain a robust understanding of the basics of eCOA instrument licensing and translation processes. This will lay the groundwork for a comprehensive grasp of essential early planning strategies and timeline considerations.
• Navigate licensing agreements: Learn how to effectively and proactively tackle potential challenges when negotiating licensing agreements with copyright holders.
• Discover best practices for translation: Understand the importance of using specialized translation agencies for instrument translation and cultural adaptation.
• Streamline activities: Gain insights into optimizing licensing and translation activities to avoid timeline delays and budget overruns.
• Leverage industry resources: Understand the real impact of using questionnaire libraries and what work still remains when it comes to setting up your study globally.

Who Should Attend
Any professional at a pharmaceutical or biotechnology company involved with the planning, start-up and/or running of a clinical trial that leverages eCOA technology:

• Clinical operations (all)
• Clinical development (all)
• Patient engagement
• Site engagement
• Therapeutic area leads
• Procurement
• Medical affairs
• IT
• Clinical IT

Speakers:

Karl McEvoy, PhD
Vice President, eCOA and Patient Technologies
YPrime

Karl McEvoy has more than 12 years of experience in clinical research, operationalizing clinical trials across a range of diseases and therapeutic areas. Having worked for pharmaceutical companies/sponsors and clinical technology providers, Karl has expertise in eCOA, eConsent, translations, licensing, and library management. He has a PhD in Neuroscience from University College Dublin and a background in microbiology and drug discovery.

Jonathan Norman
Localization Services
cYPrime

With seven years of experience in localizing paper and electronic COAs, Jonathan Norman leads translation and questionnaire licensing strategies for YPrime. He develops innovative approaches to ensure quality and accuracy in translated clinical trial materials, focusing on reducing translation burdens and increasing trial diversity. Throughout his career, Norman has progressed from project manager to director roles in linguistic validation and quality assurance. He's a trusted SME in localization best practices, maintaining strong relationships with eCOA providers, pharma sponsors, and copyright holders across the clinical research industry.

Terry Rehm
Head of Thought Leadership and Public Relations
YPrime

With a passion for health care innovation and patient advocacy, coupled with three decades of communications and marketing successes with technology organizations, Terry Rehm presents relevant thought leadership topics in the most consumable ways. She brings her natural abilities of learning, synthesis and appreciating multiple perspectives to her work as a business communicator. Her efforts have contributed to the brand awareness and, ultimately, growth of each organization she has supported. With 30 years in technology communications and marketing, Rehm excels in presenting health care innovation and patient advocacy topics. Her talent for learning, synthesis and understanding diverse perspectives enhances her role as a business communicator. Rehm's work has consistently boosted brand awareness and growth across organizations.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/ecoa-instrument-licensing